Insecticides (India) Limited (INSECTICID) AI Stock Analysis

• Market Cap: ₹20.04B
• Dividend Yield: 0.73%
• Average Volume (3M): 842.00
• Price to Earnings (P/E): 13.4
• Beta (1Y): 1.05
• Revenue Growth: 2.61%
• EPS Growth: 24.65%
• Country: IN
• Employees: 1,615
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Agricultural Inputs
• EPS (TTM): 19.97
• Shares Outstanding: 29,097,837
• 10 Day Avg. Volume: 792
• 30 Day Avg. Volume: 842
• PEG Ratio: 0.32
• Price to Book (P/B): 1.69
• Price to Sales (P/S): 0.91
• P/FCF Ratio: 32.57
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 64 Neutral
• Price Target: ₹773.00 ▲(4.61% Upside)

Insecticides (India) Limited's overall stock score is driven by its strong financial performance, which is the most significant factor. However, the bearish technical indicators and moderate valuation weigh down the score. The absence of earnings call data and corporate events means these factors do not influence the score.

Insecticides (India) Limited Business Overview & Revenue Model

Company Description

Insecticides (India) Limited (INSECTICID) is a prominent player in the agrochemical sector in India, primarily engaged in the manufacturing and marketing of a wide range of insecticides, fungicides, herbicides, and plant growth regulators. Established in 1996, the company focuses on providing innovative solutions to enhance agricultural productivity while ensuring environmental sustainability. With a strong emphasis on research and development, INSECTICID has developed a diverse portfolio of products that cater to the needs of farmers across various crops and regions.

How the Company Makes Money

Insecticides (India) Limited generates revenue primarily through the sale of its agricultural chemical products, including insecticides, herbicides, and fungicides. The company operates a multi-channel distribution strategy that includes direct sales to farmers, partnerships with agricultural cooperatives, and collaborations with distributors and retailers, which helps to expand its market reach. Key revenue streams include domestic sales, where a significant portion comes from the rural farming community, and export sales to international markets. Additionally, INSECTICID invests in research and development to innovate new products, which can lead to higher profit margins. The company may also benefit from strategic partnerships or collaborations with other agribusiness firms to leverage distribution networks and enhance product offerings, contributing to its overall earnings.

Insecticides (India) Limited Financial Statement Overview

Summary

Insecticides (India) Limited demonstrates a positive financial trajectory with strong revenue and profit growth, a stable balance sheet, and healthy cash flow generation. Despite some operational and financial risks, such as fluctuating EBIT margins and rising liabilities, the company's financial health remains robust.

Income Statement

Insecticides (India) Limited has shown consistent revenue growth with a substantial increase from 14,021 million in 2021 to 19,999 million in 2025. The gross profit margin has improved significantly, indicating efficient cost management. The net profit margin has also strengthened, reflecting enhanced profitability. However, the EBIT margin has fluctuated, which suggests some operational challenges.

Balance Sheet

The company maintains a solid equity base with an increasing trend in stockholders' equity from 8,203 million in 2021 to 10,846 million in 2025. The debt-to-equity ratio is relatively low and manageable, indicating prudent leverage. The equity ratio shows a stable asset financing structure. Nonetheless, the consistent rise in total liabilities could pose future financial risks.

Cash Flow

Insecticides (India) Limited exhibits a strong free cash flow position with growth over the years, except for a dip in 2023. The operating cash flow to net income ratio indicates robust cash generation relative to reported profits. However, fluctuations in free cash flow highlight potential volatility in capital expenditure and financing activities.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	20.35B	20.00B	19.56B	17.97B	14.98B	14.12B
Gross Profit	6.61B	3.98B	2.82B	3.99B	3.79B	3.35B
EBITDA	2.42B	2.29B	1.72B	1.21B	1.73B	1.48B
Net Income	1.51B	1.42B	1.02B	632.11M	1.07B	939.03M
Balance Sheet
Total Assets	0.00	18.98B	17.13B	16.96B	13.96B	14.26B
Cash, Cash Equivalents and Short-Term Investments	666.26M	666.26M	613.50M	196.42M	360.96M	81.44M
Total Debt	0.00	1.05B	873.09M	1.63B	539.50M	1.00B
Total Liabilities	-10.85B	8.14B	7.00B	7.78B	5.27B	6.06B
Stockholders Equity	10.85B	10.85B	10.14B	9.18B	8.70B	8.20B
Cash Flow
Free Cash Flow	0.00	561.68M	1.35B	-980.91M	675.70M	1.07B
Operating Cash Flow	0.00	934.57M	1.84B	-106.33M	1.35B	1.55B
Investing Cash Flow	0.00	-377.20M	-429.91M	-864.03M	93.09M	-1.13B
Financing Cash Flow	0.00	-610.92M	-980.58M	796.80M	-1.15B	-1.04B

Insecticides (India) Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 738.90
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Positive
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:INSECTICID, the sentiment is Negative. The current price of 738.9 is above the 20-day moving average (MA) of 721.25, below the 50-day MA of 756.28, and below the 200-day MA of 762.54, indicating a bearish trend. The MACD of -16.49 indicates Negative momentum. The RSI at 29.50 is Positive, neither overbought nor oversold. The STOCH value of 23.21 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:INSECTICID.

Insecticides (India) Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ANDHRSUGAR	68 Neutral	₹10.41B	30.12	―	0.98%	13.67%	-49.78%
DALMIASUG	67 Neutral	₹27.79B	7.50	―	1.89%	17.71%	18.17%
RANASUG	66 Neutral	₹2.20B	6.02	―	―	14.60%	152.99%
INSECTICID	64 Neutral	₹20.04B	13.38	―	0.73%	2.61%	24.65%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
BAJAJHIND	49 Neutral	₹26.99B	―	―	―	-11.30%	-73.75%

Insecticides (India) Limited Corporate Events

Insecticides (India) Limited Announces Q1 FY26 Earnings Conference Call

Insecticides (India) Limited has scheduled an earnings conference call on August 13, 2025, to discuss its Q1 and FY26 financial results. The call will feature key company executives, including the Managing Director, CFO, and Chief Marketing Officer, and will provide insights into the company’s financial performance and strategic direction.